<bill session="107" type="h" number="4833" updated="2013-07-14T18:58:33-04:00">
  <state datetime="2002-05-23">REFERRED</state>
  <status>
    <introduced datetime="2002-05-23"/>
  </status>
  <introduced datetime="2002-05-23"/>
  <titles>
    <title as="introduced" type="short">Accuracy in Pharmaceutical Advertisements Act</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to establish authority for the imposition of civil penalties for direct-to-consumer advertisements that violate such Act, and for other purposes.</title>
  </titles>
  <sponsor id="400007"/>
  <cosponsors>
    <cosponsor id="400525" joined="2002-05-23"/>
    <cosponsor id="400553" joined="2002-06-06"/>
    <cosponsor id="400026" joined="2002-05-23"/>
    <cosponsor id="400527" joined="2002-06-20"/>
    <cosponsor id="400050" joined="2002-05-23"/>
    <cosponsor id="400087" joined="2002-07-09"/>
    <cosponsor id="400103" joined="2002-05-23"/>
    <cosponsor id="400143" joined="2002-06-06"/>
    <cosponsor id="400146" joined="2002-06-06"/>
    <cosponsor id="400211" joined="2002-05-23"/>
    <cosponsor id="400230" joined="2002-05-23"/>
    <cosponsor id="400295" joined="2002-06-20"/>
    <cosponsor id="400333" joined="2002-05-23"/>
    <cosponsor id="400357" joined="2002-06-21"/>
    <cosponsor id="400358" joined="2002-06-06"/>
    <cosponsor id="400378" joined="2002-07-09"/>
    <cosponsor id="400387" joined="2002-05-23"/>
    <cosponsor id="400509" joined="2002-06-20"/>
    <cosponsor id="400407" joined="2002-06-06"/>
    <cosponsor id="400425" joined="2002-05-23"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2002-05-23">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2002-06-03">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer protection"/>
    <term name="Deceptive advertising"/>
    <term name="Drug advertising"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Fines (Penalties)"/>
    <term name="Health"/>
    <term name="Law"/>
  </subjects>
  <amendments/>
  <summary>5/23/2002--Introduced.
Accuracy in Pharmaceutical Advertisements Act - Amends the Federal Food, Drug, and Cosmetic Act to impose civil penalties for misbranding prescription drugs through a direct-to-consumer advertisement should the person fail to correct or cease such advertisement after receiving written notice from the Secretary of Health and Human Services.Requires the Secretary, acting through the Commissioner of Food and Drugs, to report to the appropriate congressional committees on the prevalence of such advertisements and other, specified particulars.</summary>
</bill>
